SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000929638-15-000310
Filing Date
2015-03-05
Accepted
2015-03-05 16:49:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D body_13d.htm SC 13D 77262
2 FORM OF LOCK-UP AGREEMENT exh1.htm EX-1 35542
  Complete submission text file 0000929638-15-000310.txt   114283
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Subject) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88750 | Film No.: 15677916
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 6109777532
DEVON PARK BIOVENTURES LP (Filed by) CIK: 0001356034 (see all company filings)

IRS No.: 000000000
Type: SC 13D